0001077183-24-000031.txt : 20240227
0001077183-24-000031.hdr.sgml : 20240227
20240227162936
ACCESSION NUMBER: 0001077183-24-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stone Warren
CENTRAL INDEX KEY: 0001955295
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 24687330
MAIL ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
BUSINESS PHONE: 2397680600
MAIL ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
4
1
wk-form4_1709069363.xml
FORM 4
X0508
4
2024-02-23
0
0001077183
NEOGENOMICS INC
NEO
0001955295
Stone Warren
9490 NEOGENOMICS WAY
FORT MYERS
FL
33912
0
1
0
0
President, Clinical Services
0
Common Stock
83775
D
Stock Option (Right to Buy)
11.21
2029-12-01
Common Stock
166113
166113
D
Stock Option (Right to Buy)
19.65
2030-05-11
Common Stock
53969
53969
D
Restricted Stock Unit
0
Common Stock
28838
28838
D
Performance Stock Unit
0
2026-05-11
Common Stock
21204
21204
D
Stock Option (Right to Buy)
16.45
2024-02-23
4
A
0
42344
0
A
2034-02-23
Common Stock
42344
42344
D
Restricted Stock Unit
0
2024-02-23
4
A
0
25329
0
A
Common Stock
25329
25329
D
Performance Stock Unit
0
2024-02-23
4
A
0
25330
0
A
2027-02-23
Common Stock
25330
25330
D
On December 1, 2022, Mr. Stone was granted 166,113 stock options. These options vest ratably over the first four anniversary dates of the grant date.
On May 11, 2023, Mr. Stone was granted 53,969 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
Once vested, the shares of common stock are not subject to expiration.
On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
On February 23, 2024, Mr. Stone was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date.
On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
/s/ Ali Olivo, Attorney-in-Fact
2024-02-27